{"id":"https://openalex.org/W2160829947","doi":"https://doi.org/10.1377/hlthaff.2011.0231","title":"Despite Criticism Of The FDA Review Process, New Cancer Drugs Reach Patients Sooner In The United States Than In Europe","display_name":"Despite Criticism Of The FDA Review Process, New Cancer Drugs Reach Patients Sooner In The United States Than In Europe","publication_year":2011,"publication_date":"2011-06-17","ids":{"openalex":"https://openalex.org/W2160829947","doi":"https://doi.org/10.1377/hlthaff.2011.0231","mag":"2160829947","pmid":"https://pubmed.ncbi.nlm.nih.gov/21680577"},"language":"en","primary_location":{"id":"doi:10.1377/hlthaff.2011.0231","doi":"https://doi.org/10.1377/hlthaff.2011.0231","is_oa":false,"landing_page_url":"https://doi.org/10.1377/hlthaff.2011.0231","pdf_url":null,"source":{"id":"https://openalex.org/S4210185023","display_name":"Health Affairs","issn_l":"0278-2715","issn":["0278-2715","1544-5208","2694-233X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["anvur-scientific","dongbi-a","doyens","fnege-2","jufo-2","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315983","host_organization_name":"Project HOPE","host_organization_lineage":["https://openalex.org/P4310315983"],"host_organization_lineage_names":["Project HOPE"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Affairs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078248445","display_name":"Samantha A. Roberts","orcid":"https://orcid.org/0000-0002-4477-8231","observed_orcids":["https://orcid.org/0000-0002-4477-8231"]},"institutions":[{"id":"https://openalex.org/I865206517","display_name":"Friends of Cancer Research","ror":"https://ror.org/05gp52j69","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I865206517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samantha A. Roberts","raw_affiliation_strings":["Samantha A. Roberts (           ) is a science policy analyst at Friends of Cancer Research, in Washington, D.C"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Samantha A. Roberts (           ) is a science policy analyst at Friends of Cancer Research, in Washington, D.C","institution_ids":["https://openalex.org/I865206517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013083952","display_name":"Jeff D. Allen","orcid":"https://orcid.org/0000-0002-0586-3054","observed_orcids":["https://orcid.org/0000-0002-0586-3054"]},"institutions":[{"id":"https://openalex.org/I865206517","display_name":"Friends of Cancer Research","ror":"https://ror.org/05gp52j69","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I865206517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeff D. Allen","raw_affiliation_strings":["Jeff D. Allen is executive director of Friends of Cancer Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jeff D. Allen is executive director of Friends of Cancer Research","institution_ids":["https://openalex.org/I865206517"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048990460","display_name":"Ellen V. Sigal","orcid":"https://orcid.org/0000-0002-2708-5943","observed_orcids":["https://orcid.org/0000-0002-2708-5943"]},"institutions":[{"id":"https://openalex.org/I865206517","display_name":"Friends of Cancer Research","ror":"https://ror.org/05gp52j69","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I865206517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ellen V. Sigal","raw_affiliation_strings":["Ellen V. Sigal is chairperson and founder of Friends of Cancer Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ellen V. Sigal is chairperson and founder of Friends of Cancer Research","institution_ids":["https://openalex.org/I865206517"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I865206517"],"apc_list":null,"apc_paid":null,"fwci":17.8062,"has_fulltext":false,"cited_by_count":67,"citation_normalized_percentile":{"value":0.98922622,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":99},"biblio":{"volume":"30","issue":"7","first_page":"1375","last_page":"1381"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":0.019500000402331352,"subfield":{"id":"https://openalex.org/subfields/3605","display_name":"Health Information Management"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.018300000578165054,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-approval-time","display_name":"drug approval time","score":0.7559999823570251},{"id":"https://openalex.org/keywords/oncology-drugs","display_name":"oncology drugs","score":0.7409999966621399},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.7390000224113464},{"id":"https://openalex.org/keywords/european-medicines-agency","display_name":"European Medicines Agency","score":0.7609999775886536},{"id":"https://openalex.org/keywords/regulatory-efficiency","display_name":"regulatory efficiency","score":0.5799999833106995},{"id":"https://openalex.org/keywords/medicine-availability","display_name":"drug availability","score":0.7429999709129333},{"id":"https://openalex.org/keywords/time-to-market","display_name":"time to market","score":0.42100000381469727}],"concepts":[{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.7862154245376587},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7068568468093872},{"id":"https://openalex.org/C7991579","wikidata":"https://www.wikidata.org/wiki/Q17955","display_name":"Criticism","level":2,"score":0.655693531036377},{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.6267871856689453},{"id":"https://openalex.org/C3020340455","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Cancer drugs","level":3,"score":0.5293481945991516},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.4959195554256439},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.4716174900531769},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.4559992849826813},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.45592525601387024},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.4495828449726105},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33848893642425537},{"id":"https://openalex.org/C3116431","wikidata":"https://www.wikidata.org/wiki/Q31728","display_name":"Public administration","level":1,"score":0.3215367794036865},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.31847089529037476},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.3029220700263977},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.1674809753894806},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.09723815321922302},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011786","descriptor_name":"Quality Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1377/hlthaff.2011.0231","doi":"https://doi.org/10.1377/hlthaff.2011.0231","is_oa":false,"landing_page_url":"https://doi.org/10.1377/hlthaff.2011.0231","pdf_url":null,"source":{"id":"https://openalex.org/S4210185023","display_name":"Health Affairs","issn_l":"0278-2715","issn":["0278-2715","1544-5208","2694-233X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["anvur-scientific","dongbi-a","doyens","fnege-2","jufo-2","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315983","host_organization_name":"Project HOPE","host_organization_lineage":["https://openalex.org/P4310315983"],"host_organization_lineage_names":["Project HOPE"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Affairs","raw_type":"journal-article"},{"id":"pmid:21680577","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21680577","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health affairs (Project Hope)","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W216342353","https://openalex.org/W1648539616","https://openalex.org/W1977333072","https://openalex.org/W1988535187","https://openalex.org/W1998297552","https://openalex.org/W2011318588","https://openalex.org/W2019178040","https://openalex.org/W2033000192","https://openalex.org/W2069004591","https://openalex.org/W2085365429","https://openalex.org/W2098658911","https://openalex.org/W2102169774","https://openalex.org/W2104505549","https://openalex.org/W2115800520","https://openalex.org/W2118820600","https://openalex.org/W2134350774","https://openalex.org/W2135753750","https://openalex.org/W2157585376","https://openalex.org/W2171188310","https://openalex.org/W2331100563"],"related_works":["https://openalex.org/W4281719350","https://openalex.org/W4317495300","https://openalex.org/W4240368843","https://openalex.org/W2079673636","https://openalex.org/W2017622455","https://openalex.org/W4281743187","https://openalex.org/W2090884751","https://openalex.org/W1484368695","https://openalex.org/W4250491591","https://openalex.org/W2982614268"],"abstract_inverted_index":{"The":[0],"US":[1],"Food":[2,108],"and":[3,103,109],"Drug":[4,110],"Administration":[5],"is":[6,22],"often":[7],"criticized":[8],"as":[9],"inefficient":[10],"compared":[11],"to":[12,58,118,123],"its":[13],"European":[14,17],"counterpart,":[15],"the":[16,26,45,61,71,87,98,107],"Medicines":[18],"Agency.":[19],"This":[20],"criticism":[21],"especially":[23],"common":[24],"in":[25,70,86,93,125],"field":[27],"of":[28,44,50,106],"oncology,":[29],"where":[30],"severely":[31],"ill":[32],"patients":[33,124],"have":[34],"few":[35],"therapeutic":[36],"options.":[37],"We":[38,54],"conducted":[39],"a":[40],"direct":[41],"drug-to-drug":[42],"comparison":[43],"two":[46],"regulatory":[47],"agencies'":[48],"approvals":[49],"new":[51,67,80],"oncology":[52],"drugs.":[53],"found":[55],"that":[56,78,113],"contrary":[57],"public":[59,104],"assertions,":[60],"median":[62],"time":[63],"for":[64,66,100],"approval":[65],"cancer":[68],"medicines":[69,82,115],"United":[72,88],"States":[73,89],"was":[74],"just":[75],"six":[76],"months--and":[77],"these":[79],"anticancer":[81],"are":[83,92],"typically":[84],"available":[85,121],"before":[90],"they":[91],"Europe.":[94],"Our":[95],"findings":[96],"reinforce":[97],"need":[99],"strong":[101],"financial":[102],"support":[105],"Administration,":[111],"so":[112],"such":[114],"can":[116],"continue":[117],"be":[119],"made":[120],"speedily":[122],"need.":[126]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":8}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}